Coronavirus: US sends two million doses of unproven hydroxychloroquine drug to Brazil

Published: Updated:
Enable Read mode
100% Font Size

The United States has delivered two million doses of the antimalarial drug hydroxychloroquine (HCQ) to Brazil to fight COVID-19, the White House said Sunday, though the drug has not yet been proven effective against the coronavirus.

“HCQ will be used as a prophylactic to help defend Brazil’s nurses, doctors, and healthcare professionals against the virus. It will also be used as a therapeutic to treat Brazilians who become infected,” a statement said.

It said the US would soon also send 1,000 ventilators to Brazil, the epicenter of South America’s outbreak with nearly 500,000 confirmed cases.

“We are also announcing a joint United States-Brazilian research effort that will include randomized controlled clinical trials,” it added.

Read the latest updates in our dedicated coronavirus section.

On Saturday, Brazil registered a record 33,274 new cases of the novel coronavirus, its health ministry said, raising the total to 498,440 in a country with one of the world’s worst outbreaks.

The death toll in Brazil from COVID-19, the respiratory illness caused by the coronavirus, increased to 28,834, with 956 new deaths in the last 24 hours, the ministry said.

For all the latest headlines follow our Google News channel online or via the app.

Read more:

Coronavirus: US hospitals cut back use of hydroxychloroquine touted by Trump

French doctor Didier Raoult defiant on hydroxychloroquine despite study

President Trump again touts drug to treat coronavirus

Top Content Trending